Download Citation
Article Source:
Antitumoral Efficacy of the Protease Inhibitor Gabexate Mesilate in Colon Cancer Cells Harbouring KRAS, BRAF and PIK3CA Mutations
Brandi G,
Tavolari S,
De Rosa F,
Di Girolamo S,
Agostini V,
et al.
(2012)
Antitumoral Efficacy of the Protease Inhibitor Gabexate Mesilate in Colon Cancer Cells Harbouring KRAS, BRAF and PIK3CA Mutations.
PLOS ONE 7(7): e41347.
https://doi.org/10.1371/journal.pone.0041347